Cargando…
Influence of APOA5 Locus on the Treatment Efficacy of Three Statins: Evidence From a Randomized Pilot Study in Chinese Subjects
Pharmacogenetics or pharmacogenomics approaches are important for addressing the individual variabilities of drug efficacy especially in the era of precision medicine. One particular interesting gene to investigate is APOA5, which has been repeatedly linked with the inter-individual variations of se...
Autores principales: | Hua, Sha, Ma, Chuanxiang, Zhang, Jun, Li, Jing, Wu, Weiwei, Xu, Ning, Luo, Guanghua, Zhao, Jianrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904201/ https://www.ncbi.nlm.nih.gov/pubmed/29695967 http://dx.doi.org/10.3389/fphar.2018.00352 |
Ejemplares similares
-
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015) -
Targeting the Apoa1 locus for liver-directed gene therapy
por: De Giorgi, Marco, et al.
Publicado: (2021) -
The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction
por: Trompet, Stella, et al.
Publicado: (2022) -
National Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark
por: Dominguez, Helena, et al.
Publicado: (2010) -
Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine
por: Huang, Piao-Piao, et al.
Publicado: (2022)